Company news

Arovella Therapeutics Limited news in 2023

Arovella Therapeutics Limited's news releases, calls and decks from 2023, newest first.

View company

Arovella receives R&D tax credit of $1.94 million

November 20, 2023

Arovella licenses novel solid tumour targeting technology

October 11, 2023

Reinstatement to Quotation

October 11, 2023

Suspension from Quotation

October 11, 2023

Response to ASX Price Query

August 30, 2023

Quarterly Appendix 4C and Activities Report

July 24, 2023

Completion of oversubscribed Share Purchase Plan (SPP)

July 10, 2023

Share Purchase Plan (SPP) Closing Date Extended

June 28, 2023

Share Purchase Plan (SPP) Offer Booklet

June 14, 2023

Arovella completes $4M placement & launches $1M SPP

June 7, 2023

Arovellas OroMist R&D facility closure completed

May 1, 2023

Response to ASX Query

April 26, 2023

Response to ASX Aware Query

April 20, 2023

ALA-101 confers survival benefit in leukemia model

April 16, 2023

Arovella completes $1.65M placement

January 18, 2023

Decks in 2023